Payment overview · 2025
General Payments
1 reported records · 1 companies
Healthcare provider profile · identity verified
Allopathic & Osteopathic Physicians|Internal Medicine · GREENVILLE, SC · NPI 1467437921
Verified facts
CMS Open Payments records show Daniel Austin Grover, MD received $20.24 in general payments during 2025 across 1 reported records.
Botanix SB Inc accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Payment overview · 2025
1 reported records · 1 companies
Separate record types
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Botanix SB Inc | Unresolved — no canonical attribution shown | $20.24 | 100.0% | 1 | 2025 |
What were the payments for?
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $20.24 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| SOFDRA Normalized: sofdra |
Drug | Botanix SB Inc | $20.24 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 756 | 214 |
| Levothyroxine Sodium | Levothyroxine Sodium | 579 | 147 |
| Omeprazole | Omeprazole | 440 | 136 |
| Amlodipine Besylate | Amlodipine Besylate | 423 | 127 |
| Lisinopril | Lisinopril | 360 | 107 |
| Lorazepam | Lorazepam | 314 | 63 |
| Simvastatin | Simvastatin | 251 | 66 |
| Escitalopram Oxalate | Escitalopram Oxalate | 236 | 68 |
| Pantoprazole Sodium | Pantoprazole Sodium | 230 | 66 |
| Zolpidem Tartrate | Zolpidem Tartrate | 220 | 69 |
| Eliquis | Apixaban | 208 | 46 |
| Montelukast Sodium | Montelukast Sodium | 204 | 68 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 204 | 64 |
| Metformin Hcl Er | Metformin Hcl | 200 | 59 |
| Potassium Chloride | Potassium Chloride | 193 | 55 |
| Metoprolol Succinate | Metoprolol Succinate | 183 | 55 |
| Losartan Potassium | Losartan Potassium | 177 | 49 |
| Trazodone Hcl | Trazodone Hcl | 174 | 61 |
| Gabapentin | Gabapentin | 173 | 58 |
| Irbesartan | Irbesartan | 172 | 48 |
| Fluticasone Propionate | Fluticasone Propionate | 164 | 64 |
| Tamsulosin Hcl | Tamsulosin Hcl | 164 | 51 |
| Alendronate Sodium | Alendronate Sodium | 158 | 49 |
| Tramadol Hcl | Tramadol Hcl | 157 | 45 |
| Hydrochlorothiazide | Hydrochlorothiazide | 127 | 36 |
| Celecoxib | Celecoxib | 124 | 42 |
| Pravastatin Sodium | Pravastatin Sodium | 122 | 43 |
| Methylprednisolone | Methylprednisolone | 121 | 106 |
| Bupropion Xl | Bupropion Hcl | 120 | 32 |
| Meloxicam | Meloxicam | 119 | 37 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 118 | 25 |
| Allopurinol | Allopurinol | 113 | 31 |
| Furosemide | Furosemide | 106 | 38 |
| Finasteride | Finasteride | 105 | 37 |
| Spironolactone | Spironolactone | 97 | 36 |
| Sertraline Hcl | Sertraline Hcl | 96 | 29 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 94 | 38 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 92 | 37 |
| Famotidine | Famotidine | 91 | 27 |
| Donepezil Hcl | Donepezil Hcl | 89 | 26 |
| Alprazolam | Alprazolam | 79 | 17 |
| Memantine Hcl | Memantine Hcl | 76 | 23 |
| Duloxetine Hcl | Duloxetine Hcl | 74 | 24 |
| Clonazepam | Clonazepam | 72 | 13 |
| Fluoxetine Hcl | Fluoxetine Hcl | 70 | 24 |
| Carvedilol | Carvedilol | 69 | 24 |
| Metoprolol Tartrate | Metoprolol Tartrate | 67 | 22 |
| Ezetimibe | Ezetimibe | 60 | 14 |
| Glimepiride | Glimepiride | 60 | 17 |
| Estradiol | Estradiol | 59 | 24 |
| Synthroid | Levothyroxine Sodium | 59 | 17 |
| Citalopram Hbr | Citalopram Hydrobromide | 57 | 15 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 55 | 15 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 53 | 42 |
| Prednisone | Prednisone | 51 | 22 |
| Valsartan | Valsartan | 51 | 15 |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 49 | 11 |
| Temazepam | Temazepam | 48 | 13 |
| Repatha Sureclick | Evolocumab | 47 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 44 | 41 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 44 | 13 |
| Xarelto | Rivaroxaban | 44 | suppressed |
| Azithromycin | Azithromycin | 43 | 42 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 42 | 11 |
| Diazepam | Diazepam | 41 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 37 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 37 | 14 |
| Fluconazole | Fluconazole | 37 | 22 |
| Januvia | Sitagliptin Phosphate | 37 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 36 | 12 |
| Nystatin | Nystatin | 35 | 14 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 35 | suppressed |
| Irbesartan-Hydrochlorothiazide | Irbesartan/Hydrochlorothiazide | 34 | 11 |
| Clopidogrel | Clopidogrel Bisulfate | 33 | 12 |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 32 | suppressed |
| Ondansetron Odt | Ondansetron | 31 | 15 |
| Promethazine Hcl | Promethazine Hcl | 30 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 29 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 29 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 29 | 25 |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 29 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 28 | suppressed |
| Fenofibrate | Fenofibrate | 28 | suppressed |
| Myrbetriq | Mirabegron | 27 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 27 | suppressed |
| Chlorthalidone | Chlorthalidone | 26 | suppressed |
| Carisoprodol | Carisoprodol | 25 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 25 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 25 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 25 | 14 |
| Jardiance | Empagliflozin | 24 | suppressed |
| Pregabalin | Pregabalin | 24 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 23 | 16 |
| Tizanidine Hcl | Tizanidine Hcl | 23 | suppressed |
| Torsemide | Torsemide | 23 | suppressed |
| Lansoprazole | Lansoprazole | 22 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 22 | suppressed |
| Mirtazapine | Mirtazapine | 21 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 20 | suppressed |
| Flecainide Acetate | Flecainide Acetate | 20 | suppressed |
| Hydrocortisone | Hydrocortisone | 20 | suppressed |
| Topiramate | Topiramate | 20 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 20 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 19 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 19 | 14 |
| Quetiapine Fumarate | Quetiapine Fumarate | 19 | suppressed |
| Ramipril | Ramipril | 19 | suppressed |
| Tradjenta | Linagliptin | 19 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 18 | suppressed |
| Cephalexin | Cephalexin | 17 | 11 |
| Ipratropium Bromide | Ipratropium Bromide | 17 | suppressed |
| Ketoconazole | Ketoconazole | 17 | suppressed |
| Zolpidem Tartrate Er | Zolpidem Tartrate | 17 | suppressed |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 16 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 16 | suppressed |
| Naloxone Hcl | Naloxone Hcl | 16 | 15 |
| Premarin | Estrogens, Conjugated | 16 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 16 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 15 | suppressed |
| Ozempic | Semaglutide | 15 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 15 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 15 | suppressed |
| Aripiprazole | Aripiprazole | 14 | suppressed |
| Atenolol | Atenolol | 14 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 14 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 14 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 14 | suppressed |
| Jantoven | Warfarin Sodium | 14 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 14 | suppressed |
| Nitroglycerin | Nitroglycerin | 14 | 11 |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 14 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 14 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 14 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 14 | suppressed |
| Tramadol Hcl-Acetaminophen | Tramadol Hcl/Acetaminophen | 14 | suppressed |
| Zaleplon | Zaleplon | 14 | suppressed |
| Baclofen | Baclofen | 13 | suppressed |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 13 | suppressed |
| Dutasteride | Dutasteride | 13 | suppressed |
| Sotalol | Sotalol Hcl | 13 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 13 | 11 |
| Telmisartan | Telmisartan | 13 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 13 | suppressed |
| Amoxicillin | Amoxicillin | 12 | 12 |
| Azelastine Hcl | Azelastine Hcl | 12 | suppressed |
| Glipizide Er | Glipizide | 12 | suppressed |
| Keppra | Levetiracetam | 12 | suppressed |
| Sucralfate | Sucralfate | 12 | suppressed |
| Xifaxan | Rifaximin | 12 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 11 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 11 | suppressed |
| Colesevelam Hcl | Colesevelam Hcl | 11 | suppressed |
| Fentanyl | Fentanyl | 11 | suppressed |
| Metformin Hcl | Metformin Hcl | 11 | suppressed |
| Mounjaro | Tirzepatide | 11 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 11 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 11 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 11 | suppressed |
| Rivastigmine | Rivastigmine Tartrate | 11 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 11 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 11 | suppressed |
| Verapamil Er | Verapamil Hcl | 11 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 11 | suppressed |
Timeline
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $20.24 · 1 records | Botanix SB Inc | SOFDRA | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error